$CL

Colgate-Palmolive Reaffirms Sales Forecast On Weak Demand

Colgate-Palmolive reaffirmed its annual net sales forecast despite a quarterly rise, citing weak North America demand. In the quarter ended June 30, net sales rose 4.9% to $5.36 billion and adjusted EPS was 99 cents. North America organic sales fell 3%, with volumes down 3.9%. The company expects 2026 adjusted earnings growth in mid-single digits and warned tariffs could offset refunds.

Original reporting
Published Aug 4, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 3:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Colgate-Palmolive Reaffirms Sales Forecast On Weak Demand — source image
Decision brief

The 30-second read

$CLBearishMed
01

Why it matters

The company reaffirmed annual net sales growth of 2% to 6% and raised its 2026 adjusted earnings forecast to mid-single-digit growth, but warned new tariffs could more than offset refunds, while North America organic sales and volumes declined.

02

Market read

Guidance reaffirmation plus a raised earnings growth base is offset by weak North America volumes and explicit tariff risk, aligning with the stock’s reported 2.5% drop.

03

What to watch

Tariff refunds already received in Q2 may cushion near-term margins, and the article does not quantify how much of the tariff impact is mitigated by pricing or mix.

Relevance 7/10Novelty 6/10Timing: today, post-quarter update with reaffirmed sales outlook and raised 2026 adjusted EPS growth base

Background

Colgate-Palmolive is dealing with muted North America demand, with higher food and fuel prices weighing on lower-income shoppers.

Company-level read

Ticker impact

$CLBearishMedium confidence
Context

Colgate-Palmolive reaffirmed its annual sales forecast despite North America organic sales falling 3% and warned tariffs could offset refunds.

Expected impact

Near-term downside bias as investors weigh muted demand and tariff risk against the guidance reaffirmation.

Evidence & confidence

The article cites a 2.5% share drop, North America organic sales down 3% with volume down 3.9%, and expects new 10% and 12.5% tariffs to more than offset tariff refunds.

Market effects

Signals continued pressure on US consumer staples demand, especially in North America, and highlights tariff sensitivity for packaged goods.

Emphasizes weakness in North America volumes and category growth, potentially affecting peers with similar exposure.

Tariff assumptions tied to US policy could influence broader pricing and margin expectations across multinational consumer goods.

Counterpoint

Raised 2026 adjusted earnings growth base suggests management sees enough cost and mix support to offset demand softness.

Key entities

  • Colgate-Palmolive

    Reaffirmed annual sales forecast, raised 2026 adjusted earnings growth base, and flagged tariff headwinds amid weak North America demand.

  • Procter & Gamble

    Referenced as forecasting slower fiscal 2027 revenue growth after quarterly sales missed estimates and margins fell.

Related articles

$CLMed

Colgate-Palmolive: Base Business EPS Increases 8% As Gross Margin Expands 140 Basis Points

Colgate-Palmolive reported Q2 2026 Base Business diluted EPS up 8% to $0.99 from $0.92, driven by 140 bps gross-margin expansion to 61.5% and higher organic sales. Reported diluted EPS fell 5% to $0.86 due to $129m pretax charges tied to its Strategic Growth and Productivity Program. Net sales rose 4.9% to $5.36b. Full-year organic outlook 1% to 4%; Base Business EPS expected mid-single-digit growth.

$CLMed

Colgate-Palmolive Q2 Earnings Call Highlights

Colgate-Palmolive (NYSE:CL) CFO Stan Sutula said Q2 material costs were slightly below expectations due to higher raw-material costs offset by tariff refunds, with no meaningful additional refunds expected. Management now expects full-year gross margin roughly flat, and warned second-half raw-material and tariff costs will be higher. It plans elevated ad spending and North America share recovery; Hill’s organic sales rose 4% excluding discontinued private-label.

$CLHighAI 9/10

Colgate-Palmolive Q2 2026 slides: strong results fuel raised guidance

Colgate-Palmolive (NYSE:CL) reported Q2 2026 results on July 31. Net sales rose 4.9% to $5.36B and organic sales grew 2.4%. Base EPS increased 8% and free cash flow rose 18% YoY to $1.5B YTD. The company raised 2026 guidance, including flat gross margin outlook and higher EPS growth, and projected $350M to $550M pre-tax charges for its 2030 program.

$CLMed

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down

Colgate-Palmolive reported Q2 net earnings of $693 million, down from $743 million a year earlier, with EPS falling to $0.86 from $0.91. Net sales rose to $5.361 billion. The company confirmed FY2026 outlook and raised Base Business EPS growth to mid-single-digit from low- to mid-single-digit, and expects gross margin roughly flat. Shares were down about 2.78% premarket.

$CLMed

Colgate-Palmolive reaffirms annual sales forecast on weak North America demand

Amazon shares rally as cloud growth surges and spending outlook climbs July 31 (Reuters) - Colgate-Palmolive on Friday reaffirmed its annual sales forecast even after posting a quarterly rise as the toothpaste maker continues to grapple with muted demand in North America, sending its shares down 2.5%. Higher food and fuel prices tied to the Middle East conflict have hit lower-income shoppers hard, making it harder for U.S.